Biotechnology Companies By One Year Return
LargestBiggest EarnersMost ProfitableMost LiquidHighly LeveragedTop DividendsCapital-HeavyHighest ValuationLargest Workforce
One Year Return
| One Year Return | Efficiency | Market Risk | Exp Return | ||||
|---|---|---|---|---|---|---|---|
| 1 | MBX | MBX Biosciences, Common | 0.07 | 8.18 | 0.55 | ||
| 2 | BCAX | Bicara Therapeutics Common | 0.03 | 5.80 | 0.16 | ||
| 3 | BOLD | Boundless Bio, Common | (0.11) | 5.59 | (0.60) | ||
| 4 | DRUG | Bright Minds Biosciences | 0.14 | 126.76 | 18.21 | ||
| 5 | LBPH | Longboard Pharmaceuticals | 0.14 | 7.56 | 1.06 | ||
| 6 | MNPR | Monopar Therapeutics | 0.14 | 76.53 | 10.47 | ||
| 7 | SMMT | Summit Therapeutics PLC | 0.10 | 9.61 | 0.93 | ||
| 8 | XCUR | Exicure | 0.27 | 20.74 | 5.51 | ||
| 9 | RNA | Avidity Biosciences | 0.02 | 4.21 | 0.07 | ||
| 10 | RZLT | Rezolute | 0.03 | 4.24 | 0.12 | ||
| 11 | CAPR | Capricor Therapeutics | 0.23 | 11.37 | 2.67 | ||
| 12 | CRVS | Corvus Pharmaceuticals | 0.28 | 4.91 | 1.35 | ||
| 13 | JANX | Janux Therapeutics | 0.07 | 3.25 | 0.22 | ||
| 14 | ADMA | ADMA Biologics | 0.09 | 4.71 | 0.42 | ||
| 15 | APLT | Applied Therapeutics | 0.11 | 9.31 | 1.02 | ||
| 16 | CADL | Candel Therapeutics | (0.03) | 4.68 | (0.14) | ||
| 17 | ARQT | Arcutis Biotherapeutics | 0.00 | 3.38 | 0.00 | ||
| 18 | EWTX | Edgewise Therapeutics | 0.13 | 7.64 | 0.99 | ||
| 19 | EBS | Emergent Biosolutions | 0.04 | 6.59 | 0.24 | ||
| 20 | VKTX | Viking Therapeutics | (0.02) | 5.10 | (0.12) |
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
One Year Return is the annualized return generated from holding a security for exactly 12 months. The measure is considered to be good short-term measures of fund performance. In other words, it represents the capital appreciation of fund investments over the last year. However when the market is volatile such as in recent years, One Year Return measure can be misleading. Although One Year Fund Return indicator can give a sense of overall fund short-term potential, it is recommended to look at mid and long term return measure before selecting a particular fund or ETF. The great way to validate fund short-term performance is to compare it with other similar funds or ETFs for the same 12 months interval.